4.6 Article

An unusual presentation of acquired hypothyroidism: the Van Wyk-Grumbach syndrome

Journal

EUROPEAN JOURNAL OF ENDOCRINOLOGY
Volume 166, Issue 3, Pages 537-542

Publisher

BIOSCIENTIFICA LTD
DOI: 10.1530/EJE-11-0494

Keywords

-

Ask authors/readers for more resources

The association in young females of long-standing primary hypothyroidism, isosexual precocious pseudopuberty and multicystic enlarged ovaries was first described in 1960 by Van Wyk and Grumbach. Since then, sporadic case reports have contributed to clarifying the key features of this syndrome. The unique elements that lead to this diagnosis are FSH-dominated sexual precocity combined with a delayed bone age in the presence of hypothyroidism. It is important to recognise this syndrome because initiating simple thyroid hormone replacement completely resolves symptoms and hormone abnormalities, avoiding unnecessary investigations for malignancies or surgical intervention. We describe an 8-year-old girl with autoimmune thyroiditis and severe long-standing hypothyroidism presenting with the clinical features of Van Wyk-Grumbach syndrome, a secondary TSH-secreting adenoma and hyperprolactinaemia. In addition, this girl presented with microcytic anaemia, elevated erythrocyte sedimentation rate (ESR) and two unusual features - a newly developed streaky hyperpigmented skin lesion and parathyroid hormone suppression despite vitamin D deficiency. Thyroxine replacement normalised all hormone abnormalities and shrunk the pituitary adenoma within 9 months, but the new skin lesion persisted. We review the literature and explore the pathophysiology of known and new features that give rise to speculation indicating stimulation of the FSH G protein-coupled receptor by excessive TSH, but LH suppression by hyperprolactinaemia.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Endocrinology & Metabolism

Causes, patterns and severity of androgen excess in 487 consecutively recruited pre- and post-pubertal children

Jan Idkowiak, Yasir S. Elhassan, Pascoe Mannion, Karen Smith, Rachel Webster, Vrinda Saraff, Timothy G. Barrett, Nicholas J. Shaw, Nils Krone, Renuka P. Dias, Melanie Kershaw, Jeremy M. Kirk, Wolfgang Hogler, Ruth E. Krone, Michael W. O'Reilly, Wiebke Arlt

EUROPEAN JOURNAL OF ENDOCRINOLOGY (2019)

Article Orthopedics

Diagnostic delay is common among patients with hypophosphatasia: initial findings from a longitudinal, prospective, global registry

Wolfgang Hoegler, Craig Langman, Hugo Gomes da Silva, Shona Fang, Agnes Linglart, Keiichi Ozono, Anna Petryk, Cheryl Rockman-Greenberg, Lothar Seefried, Priya S. Kishnani

BMC MUSCULOSKELETAL DISORDERS (2019)

Article Endocrinology & Metabolism

Oral Iron for Prevention and Treatment of Rickets and Osteomalacia in Autosomal Dominant Hypophosphatemia

Wolfgang Hoegler, Klaus Kapelari

JOURNAL OF BONE AND MINERAL RESEARCH (2020)

Article Pediatrics

New Developments in the Treatment of X-Linked Hypophosphataemia: Implications for Clinical Management

Vrinda Saraff, Ruchi Nadar, Wolfgang Hoegler

PEDIATRIC DRUGS (2020)

Review Biochemistry & Molecular Biology

Mechanisms of Bone Fragility: From Osteogenesis Imperfecta to Secondary Osteoporosis

Ahmed El-Gazzar, Wolfgang Hoegler

Summary: The strength of bone material is determined by various factors, and understanding the mechanisms of rare genetic bone fragility disorders not only advances medical knowledge but also may lead to drug development for more common disorders. The main disease mechanisms underlying bone fragility associated with low bone mass include type I collagen processing, WNT signaling, TGF-β signaling, the RANKL-RANK system, and the osteocyte mechanosensing pathway.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Article Nutrition & Dietetics

Growth and Body Composition in PKU Children-A Three-Year Prospective Study Comparing the Effects of L-Amino Acid to Glycomacropeptide Protein Substitutes

Anne Daly, Wolfgang Hoegler, Nicola Crabtree, Nick Shaw, Sharon Evans, Alex Pinto, Richard Jackson, Boyd J. Strauss, Gisela Wilcox, Julio C. Rocha, Catherine Ashmore, Anita MacDonald

Summary: Protein quality and quantity are crucial for determining muscle mass. In PKU, protein substitutes play a key role in providing nitrogen and amino acids. Results of a 3-year study comparing the impact of AA and CGMP-AA on body composition and growth did not show significant differences.

NUTRIENTS (2021)

Article Nutrition & Dietetics

A Three-Year Longitudinal Study Comparing Bone Mass, Density, and Geometry Measured by DXA, pQCT, and Bone Turnover Markers in Children with PKU Taking L-Amino Acid or Glycomacropeptide Protein Substitutes

Anne Daly, Wolfgang Hoegler, Nicola Crabtree, Nick Shaw, Sharon Evans, Alex Pinto, Richard Jackson, Catherine Ashmore, Julio C. Rocha, Boyd J. Strauss, Gisela Wilcox, William D. Fraser, Jonathan C. Y. Tang, Anita MacDonald

Summary: In children with PKU, bone density is clinically normal but slightly below the population average, blood biochemistry markers are within normal ranges, and bone turnover markers show active bone turnover.

NUTRIENTS (2021)

Article Endocrinology & Metabolism

Breast satisfaction in adult women with Turner syndrome-An international survey employing the BREAST-Q questionnaire

Jan Idkowiak, Arlene Smyth, Lily Mundy, Amy Wanaguru, Helena Gleeson, Wolfgang Hoegler

Summary: This study assessed breast satisfaction in women with Turner syndrome using the validated BREAST-Q questionnaire. The findings showed that women who received estrogen replacement therapy had lower breast satisfaction scores, and those who experienced late menarche also reported lower satisfaction. These results suggest the need for further research on the impact of hormone replacement therapy types, delivery methods, doses, and timing on breast satisfaction.

CLINICAL ENDOCRINOLOGY (2023)

Review Endocrinology & Metabolism

The landscape of retesting in childhood-onset idiopathic growth hormone deficiency and its reversibility: a systematic review and meta-analysis

Elisabeth Laurer, Antonio Sirovina, Alexandra Blaschitz, Katharina Tischlinger, Rodrigo Montero-Lopez, Thomas Hoertenhuber, Marlene Wimleitner, Wolfgang Hoegler

Summary: This study systematically analyzed the reversibility of childhood-onset idiopathic isolated growth hormone deficiency (IGHD) and found that the retesting growth hormone (GH) cut-off and time point can significantly affect the reversal rates. The results suggest that there is sufficient evidence to support the reevaluation of current IGHD management guidelines and early retesting of GH should be considered.

EUROPEAN JOURNAL OF ENDOCRINOLOGY (2022)

Article Nutrition & Dietetics

Establishing the Prevalence of Osteomalacia in Arab Adolescents Using Biochemical Markers of Bone Health

Nasser M. Al-Daghri, Sobhy Yakout, Shaun Sabico, Kaiser Wani, Syed Danish Hussain, Naji Aljohani, Suma Uday, Wolfgang Hoegler

Summary: Nutrition-acquired osteomalacia is prevalent in Arab adolescents, with a higher prevalence in girls compared to boys, which is likely associated with Arab traditional clothing and diet.

NUTRIENTS (2022)

Article Endocrinology & Metabolism

Management of RANKL-mediated Disorders With Denosumab in Children and Adolescents: A Global Expert Guidance Document

Joel A. Vanderniet, Vivian Szymczuk, Wolfgang Hogler, Signe S. Beck-Nielsen, Suma Uday, Nadia Merchant, Janet L. Crane, Leanne M. Ward, Alison M. Boyce, Craig F. Munns

Summary: Denosumab is an effective treatment for RANKL-mediated disorders in children and adolescents, although it is not curative and may be used in combination with surgical or other medical treatments. Multidisciplinary planning and expert oversight are necessary to manage the risk of mineral abnormalities. More research is needed to determine optimal treatment regimens and minimize risks.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2023)

Meeting Abstract Endocrinology & Metabolism

Breast Satisfaction in adult women with Turner Syndrome - an international survey employing the BREAST-Q questionnaire

Jan Idkowiak, Arlene Smith, Lily Mundy, Amy Wanaguru, Helena Gleeson, Wolfgang Hogler

HORMONE RESEARCH IN PAEDIATRICS (2022)

Meeting Abstract Endocrinology & Metabolism

Sustained Efficacy and Safety of Burosumab, an Anti-FGF23 Monoclonal Antibody, for 88 Weeks in Children and Early Adolescents with X-Linked Hypophosphatemia (XLH)

Thomas O. Carpenter, Wolfgang Hogler, Erik Imel, Anthony A. Portale, Annemieke Boot, Agnes Linglart, Raja Padidela, William Van'T Hoff, Gary S. Gottesman, Meng Mao, Alison Skrinar, Javier San Martin, Michael P. Whyte

JOURNAL OF BONE AND MINERAL RESEARCH (2018)

Meeting Abstract Pediatrics

BUROSUMAB, A FULLY HUMAN ANTI-FGF23 MONOCLONAL ANTIBODY, FOR X-LINKED HYPOPHOSPHATEMIA (XLH): RESULTS FROM TWO PHASE 2 TRIALS IN AFFECTED CHILDREN 1-12 YEARS OLD

William Vanthoff, Michael P. Whyte, Erik Imel, Anthony A. Portale, Annemieke Boot, Wolfgang Hogler, Agnes Linglart, Raja Padidela, Gar S. Gottesman, Meng Mao, Alison Skrinar, Javier San Martin, Thomas O. Carpenter

PEDIATRIC NEPHROLOGY (2018)

Meeting Abstract Endocrinology & Metabolism

Burosumab, a Fully Human Anti-FGF23 Monoclonal Antibody, for X-Linked Hypophosphatemia (XLH): Sustained Improvement in Two Phase 2 Trials in Affected Children 1-12 Years Old

Agnes Linglart, William Van't Hoff, Michael P. Whyte, Erik Imel, Anthony A. Portale, Annemieke Booth, Wolfgang Hogler, Raja Padidela, Meng Mao, Alison Skrinar, Javier San Martin, Thomas O. Carpenter

HORMONE RESEARCH IN PAEDIATRICS (2018)

No Data Available